share_log

DT Midstream Analyst Ratings

Benzinga ·  Oct 19, 2023 08:10
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/19/2023 3.09% Raymond James $55 → $57 Maintains Outperform
10/06/2023 -16.8% Goldman Sachs → $46 Reinstates → Sell
10/04/2023 8.52% Stifel → $60 Initiates Coverage On → Buy
09/15/2023 4.9% Mizuho → $58 Reiterates Buy → Buy
07/20/2023 4.9% Morgan Stanley $60 → $58 Maintains Underweight
05/15/2023 4.9% JP Morgan $59 → $58 Maintains Overweight
05/01/2023 4.9% Mizuho $59 → $58 Maintains Buy
04/25/2023 8.52% Morgan Stanley $64 → $60 Maintains Underweight
04/18/2023 6.71% JP Morgan $60 → $59 Maintains Overweight
04/18/2023 3.09% Barclays $64 → $57 Maintains Overweight
03/02/2023 6.71% Mizuho $60 → $59 Upgrades Neutral → Buy
02/23/2023 -2.33% Citigroup → $54 Upgrades Sell → Neutral
02/17/2023 8.52% Mizuho $62 → $60 Maintains Neutral
01/18/2023 15.75% Barclays $67 → $64 Maintains Overweight
12/16/2022 12.14% Wells Fargo $68 → $62 Downgrades Overweight → Equal-Weight
12/09/2022 -2.33% Citigroup → $54 Initiates Coverage On → Sell
11/16/2022 Wolfe Research Downgrades Outperform → Peer Perform
10/31/2022 12.14% Mizuho $57 → $62 Downgrades Buy → Neutral
10/31/2022 21.18% Barclays $63 → $67 Maintains Overweight
10/20/2022 15.75% Morgan Stanley $60 → $64 Maintains Underweight
10/19/2022 13.94% Barclays $65 → $63 Maintains Overweight
09/30/2022 3.09% Mizuho $58 → $57 Maintains Buy
08/16/2022 12.14% Barclays $59 → $62 Maintains Overweight
08/04/2022 4.9% Mizuho $57 → $58 Maintains Buy
07/20/2022 6.71% Barclays $58 → $59 Upgrades Equal-Weight → Overweight
05/10/2022 3.09% Mizuho $55 → $57 Maintains Buy
04/28/2022 6.71% Wells Fargo $58 → $59 Maintains Overweight
04/26/2022 8.52% Morgan Stanley $54 → $60 Maintains Underweight
03/08/2022 4.9% Credit Suisse $55 → $58 Downgrades Outperform → Neutral
03/04/2022 4.9% Goldman Sachs → $58 Downgrades Buy → Neutral
02/28/2022 4.9% Wells Fargo $57 → $58 Maintains Overweight
01/20/2022 -0.52% Barclays $53 → $55 Maintains Equal-Weight
01/07/2022 -2.33% Morgan Stanley → $54 Downgrades Equal-Weight → Underweight
12/16/2021 3.09% Wells Fargo $56 → $57 Maintains Overweight
10/19/2021 -4.14% Barclays $49 → $53 Maintains Equal-Weight
10/07/2021 4.9% Goldman Sachs → $58 Initiates Coverage On → Buy
09/14/2021 -4.14% Morgan Stanley → $53 Initiates Coverage On → Equal-Weight
09/13/2021 1.28% Wells Fargo → $56 Initiates Coverage On → Overweight
09/03/2021 -11.38% Barclays → $49 Initiates Coverage On → Equal-Weight
07/28/2021 -16.8% Wolfe Research → $46 Upgrades Peer Perform → Outperform
07/15/2021 -9.57% Mizuho → $50 Initiates Coverage On → Buy
07/14/2021 -5.95% JP Morgan → $52 Initiates Coverage On → Overweight

What is the target price for DT Midstream (DTM)?

The latest price target for DT Midstream (NYSE: DTM) was reported by Raymond James on October 19, 2023. The analyst firm set a price target for $57.00 expecting DTM to rise to within 12 months (a possible 3.09% upside). 20 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for DT Midstream (DTM)?

The latest analyst rating for DT Midstream (NYSE: DTM) was provided by Raymond James, and DT Midstream maintained their outperform rating.

When is the next analyst rating going to be posted or updated for DT Midstream (DTM)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of DT Midstream, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for DT Midstream was filed on October 19, 2023 so you should expect the next rating to be made available sometime around October 19, 2024.

Is the Analyst Rating DT Midstream (DTM) correct?

While ratings are subjective and will change, the latest DT Midstream (DTM) rating was a maintained with a price target of $55.00 to $57.00. The current price DT Midstream (DTM) is trading at is $55.29, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment